1976
DOI: 10.7164/antibiotics.29.1346
|View full text |Cite
|
Sign up to set email alerts
|

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
326
0
21

Year Published

1979
1979
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 915 publications
(353 citation statements)
references
References 7 publications
1
326
0
21
Order By: Relevance
“…This effect was seen more clearly in the second S-phase peak of the two cell cycles studied, where the maximum HMG CoA reductase activity always preceded the S-phase burst (19,27,28). In preliminary studies it was shown that at a compactin concentration of 2.5 ,uM, sterol synthesis in the BHK-21 cell line was inhibited over a 1-hr period by at least 95%.…”
Section: Resultsmentioning
confidence: 91%
“…This effect was seen more clearly in the second S-phase peak of the two cell cycles studied, where the maximum HMG CoA reductase activity always preceded the S-phase burst (19,27,28). In preliminary studies it was shown that at a compactin concentration of 2.5 ,uM, sterol synthesis in the BHK-21 cell line was inhibited over a 1-hr period by at least 95%.…”
Section: Resultsmentioning
confidence: 91%
“…27 This first member of the group was isolated as an antibiotic product of P. brevicompactum. 28 At about the same time, it was found by Endo et al 29 as a cholesterolemic product of Penicillium citrinum. Although compactin was not of commercial importance, its derivatives achieved strong medical and commercial success.…”
Section: Anti-rejection Drugs (Agents That Suppress the Immune System)mentioning
confidence: 85%
“…Hydroxymethylglutaryl-coenzyme A inhibitors (HMG-CoA inhibitors, or statins) were initially identified as fungal extracts in 1976 (1). They were subsequently developed as cholesterol-lowering drugs, and have been shown in numerous clinical trials to reduce both cardiovascular morbidity and mortality (2)(3)(4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%